We tested several combinations of cytokines expressed by LVs in DC precursors and showed that combined expression of GM-CSF and IL-4 was sufficient to promote their autonomous differentiation into highly viable human and murine DCs, capable to stimulate potent T cell responses against melanoma [41, 42]. The gene discussed is CSF2; the disease is melanoma.